Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-010649
Filing Date
2025-08-07
Accepted
2025-08-07 07:35:15
Documents
104
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20250630x10q.htm   iXBRL 10-Q 2574598
2 EX-31.1 coll-20250630xex31d1.htm EX-31.1 12973
3 EX-31.2 coll-20250630xex31d2.htm EX-31.2 13000
4 EX-32.1 coll-20250630xex32d1.htm EX-32.1 7551
5 EX-32.2 coll-20250630xex32d2.htm EX-32.2 7392
6 GRAPHIC coll-20250630x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001558370-25-010649.txt   12848516

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20250630.xsd EX-101.SCH 85054
8 EX-101.CAL coll-20250630_cal.xml EX-101.CAL 113957
9 EX-101.DEF coll-20250630_def.xml EX-101.DEF 325320
10 EX-101.LAB coll-20250630_lab.xml EX-101.LAB 656664
11 EX-101.PRE coll-20250630_pre.xml EX-101.PRE 522899
107 EXTRACTED XBRL INSTANCE DOCUMENT coll-20250630x10q_htm.xml XML 2775106
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 251191633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)